Financials Aurora Cannabis Inc. Nasdaq

Equities

ACB

CA05156X8504

Pharmaceuticals

Market Closed - Nasdaq 21:00:00 25/06/2024 BST 5-day change 1st Jan Change
4.71 USD -7.47% Intraday chart for Aurora Cannabis Inc. -17.66% -1.09%

Valuation

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 1,473 2,314 1,070 321.6 323.4 352.4 - -
Enterprise Value (EV) 1 1,842 2,292 858.3 248.3 323.4 352.4 352.4 352.4
P/E ratio -0.45 x -2.85 x -0.62 x -1.52 x -3.9 x -15.8 x -152 x 15.8 x
Yield - - - - - - - -
Capitalization / Revenue 5.28 x 9.43 x 4.83 x 1.84 x 1.2 x 1.17 x 1.01 x 0.87 x
EV / Revenue 5.28 x 9.43 x 4.83 x 1.84 x 1.2 x 1.17 x 1.01 x 0.87 x
EV / EBITDA -7.17 x -20.3 x -21 x -57.2 x 25.4 x 20.6 x 9.72 x 6.04 x
EV / FCF -2.13 x -8.78 x -7.53 x -2.52 x - -13.6 x 20.9 x -
FCF Yield -47% -11.4% -13.3% -39.7% - -7.35% 4.78% -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 9,741 19,798 21,477 34,213 54,539 54,549 - -
Reference price 2 151.2 116.9 49.80 9.400 5.930 6.460 6.460 6.460
Announcement Date 22/09/20 27/09/21 20/09/22 14/06/23 20/06/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Net sales 1 278.9 245.5 221.3 175 270.3 302.4 349.8 405
EBITDA 1 -205.3 -114.1 -51.05 -5.625 12.75 17.12 36.24 58.37
EBIT 1 -491 -282.8 -231.4 -158.1 -46.45 -46.55 6.392 42.9
Operating Margin -176.03% -115.21% -104.57% -90.36% -17.19% -15.39% 1.83% 10.59%
Earnings before Tax (EBT) 1 -3,384 -699.8 -1,720 -221.5 -59.6 -3.004 9.348 -
Net income 1 -3,310 -695.1 -1,718 -199 -65.58 -19.56 -1.358 18.69
Net margin -1,186.9% -283.17% -776% -113.73% -24.26% -6.47% -0.39% 4.61%
EPS 2 -339.4 -41.00 -79.90 -6.200 -1.520 -0.4100 -0.0425 0.4100
Free Cash Flow 1 -693 -263.7 -142.1 -127.8 - -25.9 16.85 -
FCF margin -248.46% -107.41% -64.18% -73.03% - -8.56% 4.82% -
FCF Conversion (EBITDA) - - - - - - 46.49% -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 22/09/20 27/09/21 20/09/22 14/06/23 20/06/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Maart 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 50.43 50.22 49.26 61.68 61.68 64.03 75.11 63.42 64.42 67.41 77.57 70.01 72.78 78.61
EBITDA 1 -12.26 -12.85 -8.7 1.428 1.428 0.31 2.155 3.398 4.349 1.891 2.35 3.021 4.527 6.96
EBIT -72.38 -63.9 -53.82 -71.6 -71.6 -32.68 -16.11 -11.05 -23.89 3.15 - - - -
Operating Margin -143.52% -127.25% -109.26% -116.08% -116.08% -51.05% -21.45% -17.42% -37.09% 4.67% - - - -
Earnings before Tax (EBT) 1 -1,012 -620.1 -63.86 -67.28 -67.28 -90.39 -22.11 0.384 -25.28 -14.04 -4.424 -0.5905 -7.188 6.615
Net income 1 -1,012 -618.8 -51.6 -65.39 -67.2 -82 -26.9 -0.523 -25.56 -21.12 -6.948 -7.881 -5.477 -2.07
Net margin -2,006.93% -1,232.28% -104.75% -106.02% -108.95% -128.07% -35.81% -0.82% -39.68% -31.34% -8.96% -11.26% -7.53% -2.63%
EPS 2 -47.20 -25.90 -1.700 -2.000 -2.000 -2.500 -0.8000 - -0.5000 -0.4100 -0.1300 - - -
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 12/05/22 20/09/22 10/11/22 10/02/23 09/02/23 14/06/23 10/08/23 09/11/23 08/02/24 20/06/24 - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: Maart 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 369 - - - - - - -
Net Cash position - 21.9 211 73.3 - - - -
Leverage (Debt/EBITDA) -1.797 x - - - - - - -
Free Cash Flow 1 -693 -264 -142 -128 - -25.9 16.9 -
ROE (net income / shareholders' equity) -11.7% -12.4% -11.6% - - -0.8% 4.3% 9.8%
ROA (Net income/ Total Assets) -9.21% -9.65% -8.46% - - -0.4% 2.2% 5.1%
Assets 1 35,943 7,205 20,315 - - 4,889 -61.72 366.4
Book Value Per Share - - - - - - - -
Cash Flow per Share 2 -34.60 -12.50 -5.110 - - 0.2200 0.7800 1.190
Capex 1 355 53.1 32.2 12.1 - 10.5 11.6 12.8
Capex / Sales 127.29% 21.62% 14.55% 6.93% - 3.48% 3.33% 3.16%
Announcement Date 22/09/20 27/09/21 20/09/22 14/06/23 20/06/24 - - -
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
6.46 CAD
Average target price
9.619 CAD
Spread / Average Target
+48.90%
Consensus
  1. Stock Market
  2. Equities
  3. ACB Stock
  4. ACB Stock
  5. Financials Aurora Cannabis Inc.